Literature DB >> 7902181

Pharmacological activity of (-)-discretamine, a novel vascular alpha-adrenoceptor and 5-hydroxytryptamine receptor antagonist, isolated from Fissistigma glaucescens.

F N Ko1, S M Yu, M J Su, Y C Wu, C M Teng.   

Abstract

1. The pharmacological activity of (-)-discretamine, isolated from Fissistigma glaucescens, was determined in rat isolated thoracic aorta, cardiac tissues and ventricular myocytes and guinea-pig isolated trachea. 2. (-)-Discretamine was found to be an alpha 1-adrenoceptor blocking agent in rat thoracic aorta as revealed by its competitive antagonism of noradrenaline (pA2 = 7.20 +/- 0.10)- or phenylephrine (pA2 = 7.60 +/- 0.09)-induced vasoconstriction. It was as potent as phentolamine (pA2 = 7.51 +/- 0.10), but was more potent than yohimbine (pA2 = 6.18 +/- 0.06). Removal of endothelium significantly increased the antagonistic potency of (-)-discretamine on noradrenaline (pA2 = 7.52 +/- 0.09)- or phenylephrine (pA2 = 7.90 +/- 0.09)-induced vasoconstriction. 3. (-)-Discretamine was also an alpha 2-adrenoceptor blocking agent (pA2 = 6.30 +/- 0.15) and a 5-hydroxytryptamine antagonist (pA2 = 6.87 +/- 0.06), both in rat aorta denuded of endothelium. 4. (-)-Discretamine protected alpha-adrenoceptors from alkylation by the irreversible blocking agent, phenoxybenzamine. 5. [3H]-inositol monophosphate formation caused by noradrenaline (3 microM) in rat thoracic aorta was suppressed by (-)-discretamine (10 and 30 microM) and prazosin (3 microM). 6. A high concentration of (-)-discretamine (30 microM) did not affect the contraction induced by the thromboxane receptor agonist U-46619, prostaglandin F2 alpha (PGF2 alpha), angiotensin II, high K+ or endothelin in rat aorta denuded of endothelium. Neither cyclic AMP nor cyclic GMP content of rat thoracic aorta was changed by (-)-discretamine. 7. Contraction of guinea-pig trachea caused by histamine, leukotriene C4 or carbachol was not affected by (-)-discretamine (30 microM). (-)-Discretamine also did not block beta l- or beta2-adrenoceptor-mediated responses induced by isoprenaline in rat right atria and guinea-pig trachea.8. A voltage clamp study in rat ventricular single myocytes revealed that sodium inward current, slow inward Ca2+ current or transient (ItO) and steady state (I800) outward current was not affected by(-)-discretamine (30 microM).9. It is concluded that (-)-discretamine is a selective x-adrenoceptor and 5-HT receptor antagonist in vascular smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7902181      PMCID: PMC2175899          DOI: 10.1111/j.1476-5381.1993.tb13895.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  Effects of calcium ions and local anesthetics on electrical properties of Purkinje fibres.

Authors:  S WEIDMANN
Journal:  J Physiol       Date:  1955-09-28       Impact factor: 5.182

2.  A uniform enzymatic method for dissociation of myocytes from hearts and stomachs of vertebrates.

Authors:  R Mitra; M Morad
Journal:  Am J Physiol       Date:  1985-11

Review 3.  Physiologic functions of normal endothelial cells.

Authors:  E A Jaffe
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

Review 4.  Alpha 1-adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+.

Authors:  K P Minneman
Journal:  Pharmacol Rev       Date:  1988-06       Impact factor: 25.468

Review 5.  Cyclic guanosine monophosphate as a mediator of vasodilation.

Authors:  F Murad
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

6.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

7.  Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells.

Authors:  M Hirata; K P Kohse; C H Chang; T Ikebe; F Murad
Journal:  J Biol Chem       Date:  1990-01-25       Impact factor: 5.157

8.  Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.

Authors:  J M Van Nueten; P A Janssen; J Van Beek; R Xhonneux; T J Verbeuren; P M Vanhoutte
Journal:  J Pharmacol Exp Ther       Date:  1981-07       Impact factor: 4.030

9.  Stimulation of alpha 1-adrenoceptors in rat kidney mediates increased inositol phospholipid hydrolysis.

Authors:  C B Neylon; R J Summers
Journal:  Br J Pharmacol       Date:  1987-06       Impact factor: 8.739

10.  Receptor mechanisms for 5-hydroxytryptamine in rabbit arteries.

Authors:  J L Black; R J French; E J Mylecharane
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

View more
  6 in total

1.  The effect of S-(+)-boldine on the alpha 1-adrenoceptor of the guinea-pig aorta.

Authors:  S Chuliá; J Moreau; E Naline; M A Noguera; M D Ivorra; M P D'Ocón; C Advenier
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

2.  Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.

Authors:  S M Yu; S C Kuo
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

3.  Pharmacological characteristics of liriodenine, isolated from Fissistigma glaucescens, a novel muscarinic receptor antagonist in guinea-pigs.

Authors:  C H Lin; G J Chang; M J Su; Y C Wu; C M Teng; F N Ko
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

4.  (-)-Discretamine, a selective alpha 1D-adrenoceptor antagonist, isolated from Fissistigma glaucescens.

Authors:  F N Ko; J H Guh; S M Yu; Y S Hou; Y C Wu; C M Teng
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

5.  Defined Small Molecules Produced by Himalayan Medicinal Plants Display Immunomodulatory Properties.

Authors:  Phurpa Wangchuk; Simon H Apte; Michael J Smout; Penny L Groves; Alex Loukas; Denise L Doolan
Journal:  Int J Mol Sci       Date:  2018-11-06       Impact factor: 5.923

6.  Scoulerine affects microtubule structure, inhibits proliferation, arrests cell cycle and thus culminates in the apoptotic death of cancer cells.

Authors:  Klara Habartova; Radim Havelek; Martina Seifrtova; Karel Kralovec; Lucie Cahlikova; Jakub Chlebek; Eva Cermakova; Nadezda Mazankova; Jana Marikova; Jiri Kunes; Lucie Novakova; Martina Rezacova
Journal:  Sci Rep       Date:  2018-03-19       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.